The use of claims databases for outcomes research: Rationale, challenges, and strategies

被引:137
作者
Motheral, BR [1 ]
Fairman, KA [1 ]
机构
[1] EXPRESS SCRIPTS INC, OUTCOMES RES, MARYLAND HTS, MO USA
关键词
claims database research; outcomes research;
D O I
10.1016/S0149-2918(97)80122-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Health care payers and policy makers need information about the cost and effectiveness of medical treatments, While randomized controlled trials historically are the primary source of medical information, they are expensive and labor-intensive, and often have limited utility for answering questions about ''real-world'' patient populations. These problems have led to an increasing reliance on claims database research in making policy decisions about treatment options. However, both researchers and decision makers should recognize the limitations and unique features of claims databases. Recommendations for avoiding or minimizing threats to internal validity, construct validity, and external validity are: (1) use of a study design that includes comparisons; (2) ensuring that the study design and conclusions are consistent with the database; (3) a priori conceptual modeling of the research question; (4) use of appropriate constructs; (5) explicit examination of alternative explanations for study findings; (6) sensitivity analyses of key assumptions; (7) awareness of the distinction between statistical and practical significance of findings; (8) generalization only when appropriate; and (9) reporting of relevant in formation, Given that any study design or data source has limitations, we hope that this paper will encourage a philosophy of methodological pluralism in outcomes research. Awareness and accurate reporting of validity issues will strengthen and extend the information resources currently available to decision makers.
引用
收藏
页码:346 / 366
页数:21
相关论文
共 76 条
  • [1] DISCONTINUATION OF ANTIHYPERLIPIDEMIC DRUGS - DO RATES REPORTED IN CLINICAL-TRIALS REFLECT RATES IN PRIMARY-CARE SETTINGS
    ANDRADE, SE
    WALKER, AM
    GOTTLIEB, LK
    HOLLENBERG, NK
    TESTA, MA
    SAPERIA, GM
    PLATT, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (17) : 1125 - 1131
  • [2] ANDREWS JM, 1994, AM J MED S6A, V97, pS245
  • [3] INCREASED ANTIDEPRESSANT USE IN PATIENTS PRESCRIBED BETA-BLOCKERS
    AVORN, J
    EVERITT, DE
    WEISS, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 255 (03): : 357 - 360
  • [4] Broadhead W E, 1994, Arch Fam Med, V3, P319, DOI 10.1001/archfami.3.4.319
  • [5] THE EFFECT OF OFFICE VISIT COPAYMENTS ON UTILIZATION IN A HEALTH MAINTENANCE ORGANIZATION
    CHERKIN, DC
    GROTHAUS, L
    WAGNER, EH
    [J]. MEDICAL CARE, 1989, 27 (11) : 1036 - 1045
  • [6] COLLET JP, 1994, PHARMACOEPIDEM DR S, P609
  • [7] Cramer J. A., 1995, American Journal of Managed Care, V1, P167
  • [8] CUSTER WS, 1991, INQUIRY-J HEALTH CAR, V28, P81
  • [9] DAGOSTINO RB, 1995, MED CARE, V33, pAS95
  • [10] Day, 1979, QUASIEXPERIMENTATION, V351